<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01460212</url>
  </required_header>
  <id_info>
    <org_study_id>QYK09184</org_study_id>
    <nct_id>NCT01460212</nct_id>
  </id_info>
  <brief_title>Magnetic Resonance Imaging Study of Cognitive-Behavior Therapy for Major Depressive Disorder</brief_title>
  <official_title>Magnetic Resonance Imaging Study of Cognitive-Behavior Therapy for Major Depressive Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nanjing Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study hypothesis: psychotherapy and SSRI treatment effect in different brain way:
      psychotherapy in &quot;up to down&quot; way and SSRI in &quot;down to up&quot; way. The investigators will
      explore this hypothesis in major depressive disorder outpatients with Magnetic Resonance
      Imaging analysis in this study. Patients in different groups will be treated by psychotherapy
      or SSRI treatment. They will all be checked with Magnetic Resonance Imaging pro and after 12
      weeks of treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients meeting the inclusion criteria undergo an examination that included a diagnostic
      interview, vision test, and psychophysiological measures. Participants then undergo the
      baseline fMRI scan within 48 hours, after that, they will receive psychotherapy or SSRI
      treatment.and returned the scan once they completed the therapy.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2011</start_date>
  <completion_date type="Anticipated">October 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hamilton Rating Scale for Depression (HAMD)</measure>
    <time_frame>an expected average of 6 months</time_frame>
    <description>The 24-item version of the Hamilton Rating Scale for Depression (HAMD; Hamilton, 1960) will be used for measuring severity of depressive symptoms. Minimum and maximum possible values are respectively 0 and 78. Lower scores show more mild depression.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Magnetic Resonance Imaging</measure>
    <time_frame>an expected average of 6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Major Depressive Disorder</condition>
  <arm_group>
    <arm_group_label>Cognitive-Behavior Therapy group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>treatment with Cognitive-Behavior Therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SSRI antidepressants</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>treatment by SSRI antidepressant</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>SSRI antidepressants</intervention_name>
    <description>SSRI antidepressants are Selective serotonin reuptake inhibitors. They include fluoxetine (Prozac); sertraline (Zoloft); paroxetine (Paxil); citalopram (Celexa) ;escitalopram (Lexapro) and fluvoxamine (Luvox). It will be chosen according to special condition of every patient.</description>
    <arm_group_label>SSRI antidepressants</arm_group_label>
    <other_name>fluoxetine (Prozac)</other_name>
    <other_name>sertraline (Zoloft)</other_name>
    <other_name>paroxetine (Paxil)</other_name>
    <other_name>citalopram (Celexa)</other_name>
    <other_name>escitalopram (Lexapro)</other_name>
    <other_name>fluvoxamine (Luvox)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive-Behavior Therapy</intervention_name>
    <description>The essence of CBT is a learning process through which an appropriate pattern in cognitive and behavioral could be learn and stored as memory</description>
    <arm_group_label>Cognitive-Behavior Therapy group</arm_group_label>
    <other_name>cognitive behavioural therapy（CBT）</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  meet SCID -Ⅰ/P major depressive disorder diagnosis;

          -  Right handedness;

          -  good visual acuity.

        Exclusion Criteria:

          -  neurological disease ;

          -  serious physical illness (e.g. heart, lung, liver, kidney or blood system disease);

          -  with other mental disorder;

          -  psychotic symptoms

          -  personality disorders;

          -  pregnancy;

          -  suicidal risk;

          -  treatment by antidepressants or other psychotropic medications within 6 months prior
             to the start of the trial;

          -  with contraindication for MRI
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chun Wang, doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nanjing Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chun Wang, doctor</last_name>
    <phone>86 15850566376</phone>
    <email>fm51109@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Nanjing Brain Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210029</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Chun Wang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 24, 2011</study_first_submitted>
  <study_first_submitted_qc>October 25, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 26, 2011</study_first_posted>
  <last_update_submitted>September 24, 2014</last_update_submitted>
  <last_update_submitted_qc>September 24, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 25, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Nanjing Medical University</investigator_affiliation>
    <investigator_full_name>Chun Wang</investigator_full_name>
    <investigator_title>The attending physician, Dr.</investigator_title>
  </responsible_party>
  <keyword>Cognitive-Behavior Therapy</keyword>
  <keyword>Magnetic Resonance Imaging</keyword>
  <keyword>major depressive disorder</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antidepressive Agents</mesh_term>
    <mesh_term>Citalopram</mesh_term>
    <mesh_term>Sertraline</mesh_term>
    <mesh_term>Fluoxetine</mesh_term>
    <mesh_term>Paroxetine</mesh_term>
    <mesh_term>Fluvoxamine</mesh_term>
    <mesh_term>Dexetimide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

